Target intelligence / Profile preview

Lepidium meyenii

Molecular classification
Other
01

Overview

Lepidium meyenii, commonly known as Maca root, is a biennial herbaceous plant native to the high Andean mountains of Peru (Gonzales, 2012, PMID: 21961034). It is classified as a dietary supplement and adaptogen rather than a specific therapeutic target like a receptor or enzyme. The root contains a variety of bioactive compounds, including unique alkaloids known as macamides, as well as glucosinolates, sterols, and polyphenols (Wu et al., 2021, PMID: 33508601). Maca is primarily utilized for its purported benefits in enhancing libido, improving fertility, and alleviating symptoms of menopause, although it does not significantly alter serum testosterone or estrogen levels in most clinical studies (NIH NCCIH, 2020). Its pharmacological effects are thought to be mediated through the modulation of the endocrine system and the inhibition of fatty acid amide hydrolase (FAAH), which affects the endocannabinoid system. Additionally, Maca may interact with hormone-sensitive medications such as tamoxifen or anastrozole due to its potential, though poorly understood, estrogenic activity (Memorial Sloan Kettering Cancer Center, 2023). Because Maca root is a complex botanical mixture, it is considered an incorrect entry for a specific molecular target database.

Other names
MacaMaca rootPeruvian ginsengMainoAyak chichiraAyak willku
02

Mechanism of action

Maca root acts through a multi-component mechanism involving the modulation of the hypothalamus-pituitary-adrenal (HPA) axis and the endocannabinoid system. Specifically, macamides found in Maca have been shown to inhibit fatty acid amide hydrolase (FAAH), which increases levels of endogenous cannabinoids like anandamide (Wu et al., 2021, PMID: 33508601). It also contains glucosinolates and polyphenols that contribute to its antioxidant and potential estrogenic or anti-estrogenic effects depending on the physiological context (Gonzales, 2012, PMID: 21961034).

03

Biological functions

Other
04

Disease associations

Other
05

Safety considerations

Goitrogenic activity due to glucosinolatesPotential hormonal interference in breast or uterine cancerInsomniaIncreased heart ratePotential for lead contamination in poorly sourced supplements
06

Interacting drugs

Tamoxifen

3 more in the full profile.

07

Biomarkers

Sperm countSperm motilitySerum Luteinizing Hormone (LH)Serum Follicle-Stimulating Hormone (FSH)Serum testosterone levels

Beyond the preview

Go deeper on Lepidium meyenii.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lepidium meyenii.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call